-
It's our monthly medical roundtable, when we dive into the month's most significant health headlines.
-
Alex Azar advanced Canadian drug importation as Donald Trump’s secretary of Health and Human Services. Now he chairs the board of a company managing Florida’s importation program.
-
The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.
-
AHCA Secretary Jason Weida told a state House panel he is “cautiously optimistic” the FDA will approve the plan, which the state has been pursuing since 2019.
-
Colorado, New Hampshire and New Mexico are also seeking federal permission to import cost-lowering prescription drugs from Canada. President Joe Biden endorsed the approach in his 2020 campaign but has yet to approve any state plan.
-
The lawsuit, filed in federal court in Tampa, came after AHCA Secretary Simone Marstiller submitted a Freedom of Information Act request seeking numerous records about importation proposals by Florida and other states.
-
The Trump’ administration approved a rule in 2020 to help clear the way, but groups including the Pharmaceutical Research & Manufacturers of America launched a legal challenge that remains unresolved.
-
At Gov. Ron DeSantis' direction, AHCA files a friend-of-the-court brief siding with the federal government in a lawsuit filed by a pharmaceutical industry group.
-
Over the objections of drugmakers, the Trump administration is expected within weeks to finalize its plan that would allow states to import some…
-
If there’s one area of health care where Republicans and Democrats might strike a deal, it’s prescription drugs. President Donald Trump has floated a plan…